G. Gulbol Duran Et Al. , "Investigation of the Relationship Between Serum Solubl Fas (sFas), Soluble Fas Ligand (sFasL) Levels and FAS-FASLG Polymorphisms in Patients with Multiple Sclerosis," Dicle Tıp Dergisi , vol.47, no.2, pp.331-339, 2020
Gulbol Duran, G. Et Al. 2020. Investigation of the Relationship Between Serum Solubl Fas (sFas), Soluble Fas Ligand (sFasL) Levels and FAS-FASLG Polymorphisms in Patients with Multiple Sclerosis. Dicle Tıp Dergisi , vol.47, no.2 , 331-339.
Gulbol Duran, G., MELEK, I., DUMAN, T., & Gunesacar, R., (2020). Investigation of the Relationship Between Serum Solubl Fas (sFas), Soluble Fas Ligand (sFasL) Levels and FAS-FASLG Polymorphisms in Patients with Multiple Sclerosis. Dicle Tıp Dergisi , vol.47, no.2, 331-339.
Gulbol Duran, GÜLAY Et Al. "Investigation of the Relationship Between Serum Solubl Fas (sFas), Soluble Fas Ligand (sFasL) Levels and FAS-FASLG Polymorphisms in Patients with Multiple Sclerosis," Dicle Tıp Dergisi , vol.47, no.2, 331-339, 2020
Gulbol Duran, GÜLAY G. Et Al. "Investigation of the Relationship Between Serum Solubl Fas (sFas), Soluble Fas Ligand (sFasL) Levels and FAS-FASLG Polymorphisms in Patients with Multiple Sclerosis." Dicle Tıp Dergisi , vol.47, no.2, pp.331-339, 2020
Gulbol Duran, G. Et Al. (2020) . "Investigation of the Relationship Between Serum Solubl Fas (sFas), Soluble Fas Ligand (sFasL) Levels and FAS-FASLG Polymorphisms in Patients with Multiple Sclerosis." Dicle Tıp Dergisi , vol.47, no.2, pp.331-339.
@article{article, author={GÜLAY GÜLBOL DURAN Et Al. }, title={Investigation of the Relationship Between Serum Solubl Fas (sFas), Soluble Fas Ligand (sFasL) Levels and FAS-FASLG Polymorphisms in Patients with Multiple Sclerosis}, journal={Dicle Tıp Dergisi}, year=2020, pages={331-339} }